Korea Pharma: Listing Section Downgraded from Blue-chip to Mid-cap
- Listing section change: Blue-chip section → Mid-cap section (effective date: 2026-05-04)
- Reason: Qualifies for mid-cap section
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Change of Listing Section
- Company: Korean Drug (014570)
- Submission: KOSDAQ Market Division
- Receipt: 04-30-2026
- Under KRX KOSDAQ Market Division